MedTrace Logo

The Arteriovenous Vascular (AV) ACCESS Trial

NCT04646226 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2025-06-27

No results posted yet for this study

Summary

This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions

Conditions

  • End-Stage Kidney Disease
  • Hemodialysis Complication

Interventions

DEVICE

AV graft

The purpose of the surgery is to connect a large vein in the arm to a nearby artery indirectly by inserting a graft material (graft surgery)

PROCEDURE

surgical intervention for creation of a fistula

The purpose of the surgery is to connect a large vein in the arm to a nearby artery directly (fistula surgery)

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Mariana Murea, MD · Wake Forest Health Sciences

  • Matthew P Goldman, MD · Wake Forest University Health Sciences

  • Michael Allon, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-18
Primary Completion
2027-06-30
Completion
2027-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04646226 on ClinicalTrials.gov